Clinical trials
Terminated Observational Multiple Sclerosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 37 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 7 |
| Fondation Ophtalmologique Adolphe de Rothschild | 2 |
| Insel Gruppe AG, University Hospital Bern | 2 |
| BeCare Link LLC | 1 |
| Brigham and Women's Hospital | 1 |
| Children's Hospital of Philadelphia | 1 |
| EMD Serono | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Hospices Civils de Lyon | 1 |
| Jagannadha R Avasarala | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 37 |
| Multiple Sclerosis, Relapsing-Remitting | 3 |
| Optic Neuritis | 2 |
| Parkinson Disease | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Amyotrophic Lateral Sclerosis | 1 |
| Anemia, Sickle Cell | 1 |
| Arthritis, Rheumatoid | 1 |
| Autism Spectrum Disorder | 1 |
| Autoimmune Diseases | 1 |
Trials
Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.